Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | HTR6 | P50406 | 6/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.49 |
| ▸ | CXCR4 | P61073 | 4/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29567963 | 0.85 | ACHE (0.62) | LMNAHTR6SIGMAR1ACHESLC6A4 | |
| SCHEMBL1020430 | 0.85 | ACHE (0.62) | LMNAHTR6SIGMAR1ACHESLC6A4 | |
| SCHEMBL16689990 | 0.85 | ACHE (0.62) | LMNAHTR6SIGMAR1ACHESLC6A4 | |
| SCHEMBL16830451 | 0.84 | ACHE (0.60) | LMNAHTR6SIGMAR1CXCR4ACHE | |
| Bromide SCHEMBL9067059 | 0.84 | ACHE (0.60) | LMNAHTR6SIGMAR1ACHESLC6A4 | |
| Hydrochloric Acid SCHEMBL23877652 | 0.81 | L3MBTL1 (0.55) | LMNAHTR6ACHESLC6A4 | |
| SCHEMBL11585715 | 0.81 | LMNA (0.54) | LMNAHTR6SIGMAR1CXCR4ACHE | |
| SCHEMBL11586414 | 0.81 | OPRM1 (0.50) | LMNAHTR6SIGMAR1CXCR4ACHE | |
| SCHEMBL5919487 | 0.79 | SIGMAR1 (0.53) | LMNAHTR6SIGMAR1SLC6A4 | |
| SCHEMBL16855797 | 0.78 | FAAH (0.52) | LMNAHTR6SIGMAR1CXCR4SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1840145-B1 | ACETYLENE CARBAMIDE DERIVATIVES-POLYUREA POLYMERS AND MICROCAPSULES AND FORMULATIONS THEREOF FOR CONTROLLED RELEASE | FMC CORP (US) | 2017-11-08 | — | — | EP | disclosed |
| US-8828415-B2 | Microcapsules with acetylene carbamide-polyurea polymers and formulations thereof for controlled release | FMC CORPORATION | 2014-09-09 | — | — | US | disclosed |
| US-20120245027-A1 | MICROCAPSULES WITH ACETYLENE CARBAMIDE-POLYUREA POLYMERS AND FORMULATIONS THEREOF FOR CONTROLLED RELEASE | FMC CORPORATION | 2012-09-27 | — | — | US | disclosed |
| EP-2487192-A2 | Microencapsulation of clomazone by means of a refined process and specific microcapsules produced thereof | Gat Microencapsulation, AG (AT) | 2012-08-15 | — | — | EP | disclosed |
| US-8216598-B2 | Microcapsules with acetylene carbamide-polyurea polymers and formulations thereof for controlled release | GAT MICROENCAPSULATION AG (AT) | 2012-07-10 | — | — | US | disclosed |
| US-20090099024-A1 | Microcapsules With Acetylene Carbamide-Polyurea Polymers and Formulations Thereof for Controlled Release | FMC CORPORATION | 2009-04-16 | — | — | US | disclosed |
| WO-2007112934-A1 | MICROCAPSULES WITH ACETYLENE CARBAMIDE-POLYUREA POLYMERS AND FORMULATIONS THEREOF FOR CONTROLLED RELEASE | GAT MICROENCAPSULATION AG (AT) | 2007-10-11 | — | — | WO | disclosed |
| EP-1840145-A1 | Acetylene carbamide derivatives-polyurea polymers and microcapsules and formulations thereof for controlled release | GAT Microencapsulation AG (AT) | 2007-10-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099024-A1 | Microcapsules With Acetylene Carbamide-Polyurea Polymers and Formulations Thereof for Controlled Release | ACAT2, ACAT1, ACACB | LMNA 2163/4885HTR6 3301/4885SIGMAR1 967/4885 |
| US-20120245027-A1 | MICROCAPSULES WITH ACETYLENE CARBAMIDE-POLYUREA POLYMERS AND FORMULATIONS THEREOF FOR CONTROLLED RELEASE | ACAT2, ACAT1, ACACB | LMNA 2491/4885HTR6 3484/4885SIGMAR1 1317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.